Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · IEX Real-Time Price · USD
5.04
-0.12 (-2.33%)
At close: Jul 19, 2024, 4:00 PM
5.20
+0.16 (3.17%)
Pre-market: Jul 22, 2024, 7:11 AM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $181.16 million as of July 22, 2024. Its market cap has decreased by -76.25% in one year.
Market Cap
181.16M
Enterprise Value
46.97M
1-Year Change
-76.25%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $181.16M, a decrease of -62.96%. That is a compound annual growth rate of -26.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 181.20M | -65.05% |
| Dec 29, 2023 | 518.40M | 109.20% |
| Dec 30, 2022 | 247.80M | 14.51% |
| Dec 31, 2021 | 216.40M | -55.75% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 908 Devices | 193.46M |
| G1 Therapeutics | 193.45M |
| P3 Health Partners | 193.17M |
| Candel Therapeutics | 190.88M |
| Pyxis Oncology | 190.21M |
| EDAP TMS | 186.82M |
| Inhibrx | 186.74M |
| Ventyx Biosciences | 186.47M |